Latest Articles

Publication Date
Endometrial Cancer in 2026: A practical update for Irish clinicians - imt.ie

Endometrial Cancer in 2026: A practical update for Irish clinicians imt.ie

Published: July 30, 2026, 10:09 a.m.
Dr Secord on Combining Mocertatug Rezetecan With Dostarlimab in Endometrial Cancer - OncLive

Dr Secord on Combining Mocertatug Rezetecan With Dostarlimab in Endometrial Cancer OncLive

Published: July 29, 2026, 5:21 p.m.
Q&A: Are environmental chemicals and endometrial cancer linked? - The Pennsylvania State University

Q&A: Are environmental chemicals and endometrial cancer linked? The Pennsylvania State University

Published: July 28, 2026, 1 p.m.
Merck (MRK) Says KEYTRUDA Beat Chemotherapy In Phase 3 Endometrial Cancer Trial - Yahoo Finance

Merck (MRK) Says KEYTRUDA Beat Chemotherapy In Phase 3 Endometrial Cancer Trial Yahoo Finance

Published: July 27, 2026, 10:08 p.m.
Generation and Characterization of a Rdh1-iCre Line to Study Uterine Glandular Biology.

The uterus is an essential organ for fetal development in most mammals. Uterine glands, highly conserved structures in the mammalian uterus, play critical roles in the establishment and maintenance of …

Published: July 25, 2026, midnight
Dublin woman Catriona Doyle was diagnosed with endometrial cancer during surgery for ovarian cancer - RSVP Live

Dublin woman Catriona Doyle was diagnosed with endometrial cancer during surgery for ovarian cancer RSVP Live

Published: July 24, 2026, 6:04 p.m.
Assisted Reproductive Technology in Breast and Gynecologic Malignancies: Cancer Risk, Fertility Preservation, and Post-Treatment Reproductive Outcomes.

Assisted reproductive technology (ART) is increasingly utilized worldwide, yet concerns remain regarding its potential association with breast and gynecological malignancies and the safety of fertility-preservation strategies in cancer survivors. Ovarian …

Published: July 24, 2026, midnight
Cancer Risk Profile of the Levonorgestrel-Releasing Intrauterine Device: A Narrative Review.

Background/Objectives: The levonorgestrel-releasing intrauterine device (LNG-IUD) is widely used as a long-acting reversible contraceptive and as a therapeutic option for heavy menstrual bleeding, endometriosis, adenomyosis, and endometrial hyperplasia. Although its …

Published: July 23, 2026, midnight
Premenopausal and postmenopausal obesity and endometrial cancer risk: circulating biomarkers of inflammation, insulin resistance, and sex hormones as mediators - Escuela Andaluza de Salud Pública

Premenopausal and postmenopausal obesity and endometrial cancer risk: circulating biomarkers of inflammation, insulin resistance, and sex hormones as mediators Escuela Andaluza de Salud Pública

Published: July 22, 2026, 9:19 a.m.
Merck's Keytruda Meets Primary Endpoint in Phase 3 Frontline Endometrial Cancer Trial - BioPharm International

Merck's Keytruda Meets Primary Endpoint in Phase 3 Frontline Endometrial Cancer Trial BioPharm International

Published: July 16, 2026, 9:06 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!